cyproheptadine sold brand name periactin among others firstgeneration antihistamine additional anticholinergic antiserotonergic local anesthetic properties patented came medical use cyproheptadine used treat allergic reactions specifically hay evidence use purpose indicates effectiveness second generation antihistamines ketotifen loratadine shown equal results fewer side also used preventive treatment migraine study frequency migraine dramatically reduced patients within days starting treatment average frequency migraine attacks patients administration times per month decreased times per month months start use label uk countries also used offlabel treatment cyclical vomiting syndrome infants evidence use comes retrospective cyproheptadine sometimes used offlabel improve akathisia people antipsychotic used offlabel treat various dermatological conditions including psychogenic druginduced hyperhidrosis excessive prevention blister formation people epidermolysis bullosa one effects drug increased appetite weight gain led use offlabel usa purpose children wasting well people cystic also used offlabel management moderate severe cases serotonin syndrome complex symptoms associated use serotonergic drugs selective serotonin reuptake inhibitors monoamine oxidase inhibitors cases high levels serotonin blood resulting serotoninproducing carcinoid cyproheptadine sedative effects used treat insomnia similarly centrallyacting recommended dose use adverse effects gastric decontamination measures activated charcoal sometimes recommended cases overdose symptoms usually indicative cns depression conversely cns stimulation excess anticholinergic side effects mice mgkg mgkg cyproheptadine potent antihistamine inverse agonist receptor higher concentrations also anticholinergic antiserotonergic antidopaminergic activities serotonin receptors especially potent antagonist receptors thought underlie effectiveness treatment serotonin however possible blockade receptors may also contribute effectiveness serotonin cyproheptadine reported block receptors human brain dose mg three times per day mgday total block receptors human brain dose mg three times per day mgday total measured positron emission tomography dose cyproheptadine recommended ensure blockade receptors serotonin syndrome besides activity neurotransmitter targets cyproheptadine reported possess weak antiandrogenic cyproheptadine wellabsorbed following oral ingestion peak plasma levels occurring terminal halflife taken orally approximately cyproheptadine tricyclic benzocycloheptene closely related pizotifen ketotifen well tricyclic antidepressants cyproheptadine studied one small trial adjunct people schizophrenia whose condition stable medication attention verbal fluency appeared improved study small draw generalizations also studied adjuvant two trials people schizophrenia around fifty people overall appear trials see cyproheptadine could reduce sexual dysfunction caused ssri antipsychotic cyproheptadine studied treatment posttraumatic stress cyproheptadine used cats appetite adjunct treatment possible adverse effects include excitement aggressive elimination halflife cyproheptadine cats cyproheptadine second line treatment pituitary pars intermedia dysfunction httpsenwikipediaorgwikicyproheptadine